Animation-Based Caregiver-Patient Interaction Model for Postoperative Pain Management in Preschool Children with

Yu Chen1, Ying Guo1, Yao-Bin Zhu1

  • 1Beijing Children's Hospital, Capital Medical University.

Insights

An animation-based caregiver-patient interaction model effectively reduced postoperative pain and anxiety in preschool children with congenital heart disease (CHD). This non-pharmacological approach offers a safe method for managing pain and anxiety in young patients.

Area of Science:

  • Pediatric Critical Care
  • Pain Management
  • Anxiety Management

Background:

  • Preschool children with congenital heart disease (CHD) often experience significant postoperative pain and anxiety.
  • Effective pain and anxiety management is crucial for recovery in pediatric cardiac surgery patients.
  • Non-pharmacological interventions are sought as adjuncts to traditional pain management.

Purpose of the Study:

  • To evaluate an animation-based caregiver-patient interaction model for managing postoperative pain and anxiety.
  • To assess the efficacy of this model in preschool children undergoing CHD surgery.

Main Methods:

  • A randomized controlled trial involving 70 preschoolers with CHD.
  • Intervention group received standard care plus a structured animation program (preoperative selection, post-extubation viewing, nurse/parental guidance).
  • Control group received standard postoperative care. Pain and anxiety were assessed using Wong-Baker FACES and mYPAS scales at multiple time points.

Main Results:

  • The intervention group showed significantly lower pain scores at 6h, 24h, and 48h post-extubation (p < 0.001).
  • Anxiety scores were significantly lower in the intervention group during OR transport and 24h post-surgery (p < 0.001).
  • The animation model demonstrated a significant reduction in both pain and anxiety levels over time within the intervention group.

Conclusions:

  • The interactive animation model significantly reduces postoperative pain and perioperative anxiety in preschool patients with CHD.
  • This approach serves as a safe, non-pharmacological adjuvant for pain and anxiety management in this vulnerable population.
  • The model highlights the potential of integrating technology and interaction for improved pediatric patient care.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
429
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
575
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
920